Euda Health Holdings Ltd. (Singapore)

The Company operates as a healthcare specialty company. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The Company is also involved in the property management that services shopping malls, business office building, or residential apartments. The Company is headquartered in Singapore.
History
2021: The Company is a newly incorporated company incorporated on January 21, 2021, under the laws of the British Virgin Islands.
The units, ordinary shares, warrants and rights was trade on the Nasdaq Global Market (“Nasdaq”) under the symbols LAXXU, LAX, LAXXW and LAXXR, respectively.
2022: As of January 31, 2022, the Company had not yet commenced any operations. All activity for the period from January 21, 2021 through January 31, 2022 relates to the Company's formation and the proposed initial public offering.
On November 17, 2022 In addition, in connection with the consummation of the Share Purchase, 8i has changed its name to “EUDA Health Holdings Limited.”
On November 17, 2022, the Company consummated the Business Combination contemplated by the SPA between 8i, EHL, Watermark, and Kwong Yeow Liew, dated April 11, 2022 and amended May 30, 2022, June 10, 2022, and September 7, 2022. As contemplated by the SPA, a business combination between 8i and EHL was effected by the purchase by 8i of all of the issued and outstanding shares of EHL from Watermark, resulting in EHL becoming a wholly owned subsidiary of 8i.
Commencing at the open of trading on November 18, 2022, the combined company's ordinary shares and warrants will trade on Nasdaq Stock Market under the symbols “EUDA” and “EUDAW,” respectively.
On November 22, 2022, the audit committee of the Company's board of directors dismissed UHY LLP, 8i's independent registered public accounting firm prior to the Business Combination, as the Company's independent registered public accounting firm following completion of UHY's review of 8i's financial statements for the quarter ended October 31, 2022, which consists only of the accounts of the pre-Business Combination special purpose acquisition company, 8i, and appointed Marcum Asia CPAs LLP as the Company's independent registered public accounting firm to audit the Company's consolidated financial statements for the year ending December 31, 2022.